| Ytd | 7.33% | |
| 1y | -48.12% |
| Open | 2.41 | Prev Close | 2.73 | Low | 2.15 | High | 2.63 | Mkt Cap | 5.89M |
| Vol | 293.04K | Avg Vol | 1.98M | EPS | -0.36 | P/E | N/A | Forward P/E | N/A |
| Beta | 1.00 | Short Ratio | 3.35 | Inst. Own | 1.92% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 2.61 | 200-d Avg | 3.36 | 1yr Est | 0.00 |
Gainers Can Fite Biopharma (AMEX:CANF) shares rose 43.8% to $4.27 during Wednesday's regular se
expands its IP portfolio to clinical-stage biopharmaceutical assets XTL Biopharmaceuticals (XTL) Com